Search Results: Sorafenib
Sorry, the article you're looking for isn't specifically available. Here are related topics:
Natco Pharma
Selasa, 2024-03-19 21:25:05koji je proizveo Bayer, rekavši da će prodati generičke lijekove Tosilat Sorafenib za 3 posto cijene koju je Bayer iz Njemačke naplatio za original. Danas...
Click to read more »SLC46A3
Jumat, 2026-05-29 22:48:26oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy". Biomedicine & Pharmacotherapy. 114: 108864. doi:10.1016/j.biopha...
Click to read more »PDGFB
Sabtu, 2026-05-30 19:21:44Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Wnt-signalni put
Sabtu, 2026-05-30 18:33:15Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Tirozin-kinaza
Sabtu, 2026-05-30 18:35:13Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »VEGF
Sabtu, 2026-05-30 18:22:21Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Receptor faktora rasta
Sabtu, 2026-05-30 18:35:04Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »FGF2
Sabtu, 2026-05-30 18:34:30Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Receptor epidermnog faktora rasta
Sabtu, 2026-05-30 19:30:35Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »EGF
Sabtu, 2026-05-30 18:35:07Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Faktor nervnog rasta
Sabtu, 2026-05-30 18:55:59Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Trombocitni faktor rasta
Sabtu, 2026-05-30 19:30:56Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »NRTN
Sabtu, 2026-05-30 17:37:56Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Transformirajući faktor rasta alfa
Sabtu, 2026-05-30 19:30:46Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »FGF1
Sabtu, 2026-05-30 18:27:35Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »FGFR3
Sabtu, 2026-05-30 18:34:39Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Receptorska tirozin-kinaza
Sabtu, 2026-05-30 18:35:16jednjaka, Gliom 2003. Erlotinib (Tarceva) EGFR Rak jednjaka, Gliom 2004. Sorafenib (Nexavar) Raf, VEGFR, PDGFR, Flt3, KIT Karcinom bubrežnih ćelija 2005...
Click to read more »FGFR2
Sabtu, 2026-05-30 17:44:43Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »FGFR1
Sabtu, 2026-05-30 17:46:18Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »KDR
Sabtu, 2026-05-30 18:35:37Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »RET proto-onkogen
Sabtu, 2026-05-30 17:45:06Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Tumorsko mikrookruženje
Sabtu, 2026-05-30 19:45:56koju proizvode CAF i TAM. Ovi inhibitori uključuju sunitinib, pazopanib, sorafenib i axitinib, od kojih svi inhibiraju receptor trombocitnog faktora rasta...
Click to read more »FGFR4
Sabtu, 2026-05-30 18:27:39Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »VEGF-receptor
Sabtu, 2026-05-30 18:35:42Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »FGFRL1
Sabtu, 2026-05-30 18:34:42Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »Transformirajući faktor rasta
Sabtu, 2026-05-30 19:30:49Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »TNFSF18
Sabtu, 2026-05-30 19:06:57(OSM) Thymic stromal lymphopoietin (TSLP) Additional cytokine receptor modulators: Emfilermin Lestaurtinib Midostaurin Quizartinib Sorafenib Sunitinib...
Click to read more »BDNF
Sabtu, 2026-05-30 17:43:14Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »EPHA2
Sabtu, 2026-05-30 18:51:54Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »ERBB2
Sabtu, 2026-05-30 17:39:25Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »IFNGR
Sabtu, 2026-05-30 18:23:35(OSM) Thymic stromal lymphopoietin (TSLP) Additional cytokine receptor modulators: Emfilermin Lestaurtinib Midostaurin Quizartinib Sorafenib Sunitinib...
Click to read more »IGF2R
Sabtu, 2026-05-30 18:23:38Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »TNFRSF11B
Sabtu, 2026-05-30 17:46:50(OSM) Thymic stromal lymphopoietin (TSLP) Additional cytokine receptor modulators: Emfilermin Lestaurtinib Midostaurin Quizartinib Sorafenib Sunitinib...
Click to read more »Receptor insulinolikog faktora rasta 1
Sabtu, 2026-05-30 20:05:51Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »HER2
Sabtu, 2026-05-30 20:36:23Motesanib Nintedanib Pazopanib Radotinib Kvizartinib Ripretinib Sunitinib Sorafenib Toceranib Antitijela: Olaratumab Ramucirumab Tovetumab RET (GFL) GFRα1...
Click to read more »
